(lp0
S'Stock Returns: AVEO Pharmaceuticals Inc  versus Vericel ... CML News - 18 hours ago This is a snapshot to compare the stock returns for AVEO Pharmaceuticals Inc  versus Vericel Corporation  .'
p1
aS"Aveo reeling after FDA's rejection of kidney cancer drug Boston Globe - Aug 26, 2013 It took Aveo Pharmaceuticals Inc. seven years to develop a much anticipated kidney cancer drug. Federal regulators needed only about four hours to crush the company's hopes."
p2
aS"AVEO Pharmaceuticals  Q4 Earnings: What's in Store? Nasdaq - Mar 6, 2017 AVEO Pharmaceuticals, Inc . AVEO is expected to report fourth-quarter 2016 results this month. The company has an impressive track record for the last four reported quarters having beaten estimates on three occasions and meeting expectations in one ..."
p3
aS"Notable Price Swings: AVEO Pharmaceuticals, Inc.  Is stories - Mar 8, 2017 According to FactSet data, AVEO stock has received different ratings from Financial Analysts. 3 Months Ago, AVEO's stock has been recommended as BUY from 2 and 0 given OVERWEIGHT rating for the company. 0 issued rating as a HOLD.0 said as SELL&nbsp;...Stock Returns: AVEO Pharmaceuticals Inc  versus Caladrius ... - CML News16 hedge funds sold their entire positions in AVEO Pharmaceuticals, Inc.  - Post Analyst"
p4
aS'AVEO Pharmaceuticals Inc. MarketWatch - Oct 8, 2010 AVEO Pharmaceuticals Inc. NASDAQ: AVEO. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS"AVEO Pharmaceuticals, Inc.  Set to Announce Earnings on Monday Chaffey Breeze - Mar 11, 2017 AVEO Pharmaceuticals logo AVEO Pharmaceuticals, Inc.  is scheduled to be posting its quarterly earnings results before the market opens on Monday, March 13th.What Type of Consensus Views Analysts Say about AVEO Pharmaceuticals, Inc.'s ... - Hot Stocks PointThe AVEO Pharmaceuticals'  Outperform Rating Reiterated at FBR &amp; Co - DailyQuint"
p6
aS"Company Update : AVEO Pharmaceuticals, Inc. Announces Dosing of ... Smarter Analyst - May 26, 2016 AVEO Pharmaceuticals, Inc.  announced that the first patient has been dosed in the Company's pivotal TIVO-3 trial, a randomized, controlled, multi-center, open-label study to compare tivozanib to sorafenib in subjects with refractory&nbsp;..."
p7
aS"AVEO Pharmaceuticals  Pays $4M to Settle SEC Fraud Charges StreetInsider.com - Mar 29, 2016 The SEC alleges that AVEO Pharmaceuticals Inc.  concealed the FDA's level of concern about Tivozanib in public statements to investors by omitting the critical fact that FDA staff had recommended a second clinical trial to address their&nbsp;...SEC charges biotech Aveo with misleading investors - The Boston GlobeFeds charge Cambridge drug firm, former execs with misleading investors - Boston Business Journal "
p8
aS'Stock Returns: AVEO Pharmaceuticals Inc  versus CTI BioPharma ... CML News - Mar 13, 2017 This is a snapshot to compare the stock returns for AVEO Pharmaceuticals Inc  versus CTI BioPharma Corp.  .'
p9
aS'AVEO Pharmaceuticals, Inc.  Files An 8-K Market Exclusive - Oct 14, 2016 AVEO Pharmaceuticals, Inc.  received a deficiency letter from the Listing Qualifications Department  of the Nasdaq Stock Market  notifying the Company that, for the last 30 consecutive business days, the bid price ...'
p10
a.